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Introduction 
 
While a pressure flow voiding study is the definitive measure of bladder 
outlet obstruction, uroflowmetry is a simple, noninvasive test which provides 
valuable information. Flow rate measurement represents a reproducible way to 
quantify the strength of the urinary stream and, when used in combination with 
symptom scores for a small subset of patients (20%), has a high probability of 
correctly characterizing whether there is BOO1. Chancellor and colleagues2 found 
that flow rate recording cannot distinguish between BOO and impaired detrusor 
contractility as the cause for a low peak flow (Qmax). Qmax appears to predict 
surgical outcome in some studies. Although considerable uncertainty exists, 
patients with a Qmax greater than 15 ml/s appear to have somewhat poorer 
treatment outcomes after prostatectomy than patients with a Qmax of less than 15 
ml/s3.  
Uroflowmetry and measurement of post void residue (PVR) are 
recommended as diagnostic tests in the initial assessment of men with LUTS and 
should be performed prior to prostatectomy (AUA 2003, EAU 2004 guidelines for 
BPH). However, Lloyd and Kirk4 have shown that as few as 28% of surgeons 
performing resection always carry out uroflowmetry with 46% using it only 
occasionally or never. This may be attributed to the inconclusive evidence 
supporting its use. Measurement of urinary flow rate requires sophisticated 
equipment and in a developing country like India, a major deterrent to setting up a 
uroflowmetry clinic is the prohibitive cost involved.  Hence there is a need to 
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develop a simpler tool which would not only objectively quantify urinary flow but 
also be cost-effective enough to be made accessible to all practising urologists. 
Taking of a good history is the starting point in making the diagnosis of 
BOO. However, there is an element of subjectivity in the patients’ perception of 
flow symptoms. In the IPSS scoring system, the patient assesses how often the 
flow is weak. In others, e.g. Madsen and Iverson, the patient judges whether his 
stream is strong, weak or variable. Hence, the reliability of the patients’ judgement 
requires quantitative study. The Brian Peeling diagram5 consists of a multiple 
choice pictorial representation of different urinary flow strengths. The patient is 
asked to mark the flow trajectory on the Brian Peeling diagram which best 
represents his own flow. We decided to use a modification of this simple, 
inexpensive tool to assess patients’ urinary flow and compared it with the peak 
flow rate (Qmax) measured by a uroflowmeter. 
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Review of literature 
Evolution of Uroflowmetry 
The first attempt to obtain an objective measurement of urinary flow rate 
was made in 1897 by Rehfisch6. The technique was based on the principle of air 
displacement and involved the timing of the onset and completion of micturition. 
The course of micturition was recorded on a kymograph, but details of flow rate, 
voided volume, and micturition time could not be obtained. Palm and Nielsen7 
later modified the air displacement technique by incorporating a “hot wire” into the 
instrument and used it to evaluate bladder function in children. In this case, air 
displaced by the urine was directed through a transducer consisting of a nylon 
block containing a tantalum wire. The displaced air cooled the wire which was 
fixed at a constant temperature of 300°C, and the electrical energy required to 
maintain this temperature was proportional to the urine flow. Another 
displacement technique was also used by Holm8 but different from the hot wire 
models by feeding the displaced air to an anesthetic rota-meter calibrated to give 
a direct reading of the flow rate. The drawbacks to methods based on air 
displacement are that the apparatus has to be completely airtight and maintained 
at constant ambient temperature.  
After the initial studies of Rehfisch, the measurement of urinary flow was 
largely neglected for 25 years until 1922 when Schwartz and Brenner9 expressed 
flow rate in terms of the cast distance of the stream. They instructed their subjects 
to urinate, with the stream directed horizontally at the meatus, into a number of 
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containers arranged in a row in front of them. From the volume of urine falling into 
successive vessels ant the time taken to void, they were able to plot a “propulsion 
curve” and calculated that the volume expelled per unit time was approximately 20 
ml/s. Ballenger and his associates in 193210 advocate the use of the distance that 
the urinary stream can be projected as an index of progressing prostatic 
obstruction. They recognized the futility of such an exercise for the purpose of 
comparing flow rates between different individuals, but suggested that it might be 
a useful means for any one man to detect a reduction in the strength of his urinary 
stream. Thus they advised men of “forty-five or fifty years of age to make a test, 
from time to time, preferably when alone in the country or out by the barn.” The 
method of measuring the cast distance of the stream was also used by Morales 
and Romanus11.  
An even simpler approach, namely direct observation of the urinary stream 
without taking any measurements has also been advocated as a means of 
assessing voiding ability in male children12. It would be fair to say that many 
urologists not in possession of a uroflowmeter have resorted to this method at 
some stage of their career. However, although this method may provide a rough 
guide as to the strength of the stream, it can hardly be regarded as quantitative; 
and its use has not been reported for many years.  
Gronwall in 192513 was the first worker who attempted to make direct 
measurements of urinary flow rates. Urine was passed into a collecting cylinder 
which contained a float. As the level of urine in the vessel rose, the movement of 
the float was recorded by a kymograph. Gronwall observed that the individual flow 
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curves of women were steeper than those of men, and that males with prostatic 
obstruction produced curves with much flatter initial rises. A similar technique, 
based on recording the increasing weight of the voided urine was used by Drake 
in 194814. The materials used to construct the instrument were simple indeed: the 
device consisted principally of a toy erector set and screen attached to one arm of 
a balance and a 1 litre container was connected to the other arm. By fitting a 
recording pen to the spring and using a kymograph calibrated to calculate in 
100ml intervals, it was possible to calculate the flow rate in ml/s. The apparatus 
was dubbed the “uroflometer” and the recordings it produced, “uroflograms”. The 
method allowed the computation of average flow rates, and by taking 
measurements from the steepest portion of the voiding curve, the maximum flow 
rate could also be determined. This method was improved and extended by 
Kaufman15 by the addition of and automatic starting mechanism and was used to 
obtain more than 5,000 measurements of flow rates16. However, the instrument 
was inaccurate for voided volumes less than 200ml and led Stewart17, who also 
used the instrument, to conclude that uroflowmetry was of limited value in the 
diagnosis of obstruction of the lower urinary tract. It seems that Drake also was 
dissatisfied with his flowmeter, regarding it as complicated, and later invented a 
simpler “more professional-appearing” contrievance18.  It consisted of a small half 
cylinder into which the patient voided. This “weir” was mounted above a larger half 
cylinder divided into five chambers. Holes were placed in the weir at varying 
heights such that, depending on the flow rat, the urine emptied into different 
compartments in the lower cylinder. Each of the compartments corresponded to a 
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different minimum flow rate and only flow rates in excess of 20 ml/s enabled urine 
to empty into all of them. Since abnormality was defined as the inability to get 
urine into all the chambers, a flow rate of 20 ml/s was designated as the 
watershed of normality. The method required a minimum volume of 200 ml to 
obtain accurate data and was later used by von Rutishauser and Lederman19, 
although its use has since been abandoned in favour of other techniques. 
The use of the weight of voided urine as a measure of flow rate was 
adapted and improved by von Garrelts20.  A pressure transducer 
(electromanometer) at the bottom of a collecting cylinder gave a measure of the 
increasing urine volume in the cylinder, and this was recorded on a time scale. 
Electrical derivation of the pressure enabled a direct determination of the rate of 
flow throughout micturition. Von Garrelts used this instrument for an extensive 
series of studies on normal males21, urethral stricture, and prostatic disorders21, 
but later modified it23 so that the hard copy of the recording could be obtained 
instantaneously (the original one had to be photographically developed). This 
version used a container suspended on a spring which moved an iron core in a 
coil. This version had previously been used by Ross and Nixon24.  
Klein et al 25 substituted an electronic balance for the pressure transducer 
used in previous flowmeters, thereby overcoming what they stated were problems 
associated with the use of transducers. These included hydraulic resistance, 
difficulty in cleaning, blockages, and possible misinterpretation caused by bubbles 
in the urinary stream. The balance circumvented these problems by being 
frictionless. Gleason et al26 also measured urinary flow rate by utilizing the 
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changing urine weight, but did not provide details of the instrumentation. Their 
study distinguished itself by coupling urinary flow measurements with 
determinations of the energy left in the stream after transit through the urethra. 
This was achieved by measuring the impact force of the urinary stream on a 
vertical disk with a force transducer. Although novel, this concept was not 
subsequently pursued by others.  
One of the more popular notions was to measure the time taken to void a 
given volume of urine. This approach obviously provides a measure of average, 
rather than peak flow rate. Johanson in 195327 was the first to employ the 
principle, and he found that a minimum volume of 200 ml was necessary to obtain 
meaningful results. Helmstein28 varied the approach by measuring the amount of 
urine voided during the “best eight seconds”, and Hinman29 adopted a similar 
procedure, measuring the time taken to void the volume of urine between 50 and 
150 ml. The urine was allowed to flow into a graduated measuring cylinder and by 
its conductance, automatically started a stop watch when the volume reached 50 
ml. When the volume reached 150 ml, a second relay stopped the clock, the face 
of which was altered to allow a direct reading of flow rate. This method was used 
with little modification by Beck and Gaudin30 who found it useful in the 
assessment of men with prostatic obstruction. Cole et al measured the volume of 
urine voided in the first five seconds of micturition and concluded that a volume of 
less than 45 ml voided in this period was indicative of significant urethral 
narrowing. They acknowledged that this simple test was unreliable at volumes 
less than 200ml. Thus, although the estimation of average flow rate by this 
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method is simple and requires no expensive or specialized equipment, it suffers 
from several serious limitations including inaccuracies inherent in determining the 
exact time of the onset and completion of micturition and its inability to provide a 
permanent, continuous record of flow rate.  
Apart from direct visual observation of the urinary stream, perhaps the next 
most simple approach to the problem of assessing flow rate is to listen. While this 
might enable a very broad categorization of patients with extreme symptoms, it 
suffers from the same lack of quantitative objectivity as just watching a patient 
void. In 1963 Lyon and Smith31 devised a method which they stated “at first 
glance would seem too crude to be valuable”. Although this method has been 
quoted as being based on audio measurements, the calculation of flow rate 
actually entailed determining the time taken to void a measured volume and 
therefore gave an estimate of average flow rate in much the same way as other 
studies discussed previously. In this method, a tape recorder microphone was 
attached to a normal toilet seat form which was suspended a collecting vessel. 
When voiding was completed, the volume was measured, the tape recording of 
the sound replayed, and a stop watch used to determine the total voiding time. 
Thus although this technique has been cited based on audio measurements, the 
use of the tape recorder was in truth only a more complex means of enabling an 
accurate estimation of voiding time.  
Subsequently, another method based on sound measurement32 was 
published and was described by its authors as “simplicity itself”. Again, it involved 
taking a tape recording of the voiding, and “by converting the kinetic energy of the 
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velocity head from the force of the urinary stream into sound energy upon a 
magnetic tape and rectifying this audio voltage”, it was possible to obtain a 
graphic voiding curve. The flow rate was obtained by adding a time bade to the 
graph. 
In 1967 Koontz and Rowan33 published an article describing a flowmeter 
which enabled the measurement of changes in urinary flow rate per second. 
Although rather ingenious, the method was simple in concept and consisted of a 
carousel divided into 60 compartments, each of 50 ml capacity. The subject 
voided into a funnel placed above the carousel which turned one complete 
revolution per minute, and form the volume of urine collected into each 
compartment it was possible to plot a curve showing the flow rate in ml/s. There 
were obvious drawbacks to this technique, the most obvious on being the 
inconvenience of having to measure the volume in each container and to 
construct the flow curve manually. Other disadvantages  included the need to 
empty and clean the carousel after each void and the obvious problems which 
would result when patients’ flow rates exceed 50 ml/s or when they took longer 
than sixty seconds to finish voiding.  
A flowmeter which operated on the rotameter principle was also used by 
Susset et al34, and although this instrument reportedly gave a permanent 
continuous tracing form 0 to 60 ml/s, it was not described in any detail in their 
article. 
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Around 1975, a uroflowmeter based on an entirely new principle became 
commercially available. Manufactured by Disa, the machine has become generally 
known as the “rotating disk” flowmeter. A transducer consisting of a lightweight, 
rimmed plastic disk is mounted on the shaft of a D.C. motor. Urine hitting the disk 
tends to slow its speed of rotation, and the electrical energy necessary to maintain 
a constant disk velocity is proportional to the mass flow rate of urine. A stringent 
technical and clinical evaluation of this instrument performed by Rowan et al35 is 
worthy of note. Their investigation showed that inaccuracies inherent in measuring 
low flow rates with this machine were probably insignificant for most routine 
clinical applications, but that serious errors resulted at high flow rates when the 
urine struck the grid intersections or the edge of the rotating disk. These problems 
have since been largely circumvented by the substitution of the grid with a large 
collecting funnel which directs the urine stream to the center of the disk. 
One of the more sophisticated physical principles adapted to the 
measurement of urinary flow rates is that of electromagnetism. A flowmeter 
described by Cardus et al36 used and electromagnetic blood flowmeter to 
measure instantaneous urine flow rate. At first, patients were connected directly to 
the probe of the flowmeter by means of specially constructed latex rubber 
adapters. However, the adapters were not easy to use and gave rise to artifacts in 
the measurements, and the method was modified for use with a funnel which 
obviated the need for the adapters. The advantages of this technique were that it 
gave an instantaneous response and provided an accurate and permanent 
recording of the complete flow curve and increasing volume of urine.  
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A novel approach to the assessment of voiding ability was introduced by 
Bryndorf and Sondoe37 who expressed their results in terms of the velocity of the 
urinary stream, variations in which were recorded on an 8 mm film at the rate of 8 
pictures/s. Determination of the stream velocity was made from every fourth 
picture. If a horizontal jet was recorded, as was intended, the horizontal cast 
distance and the vertical distance from the urethra to the base were measured 
from the developed film,  and the equation derived by Schwartz and Brenner9. 
Deviations from the horizontal were accounted for mathematically. This technique 
suffered from some of the more common drawbacks inherent in other methods, 
and in addition, was obviously unsuitable for the female patients. 
Nonetheless, photography of the urinary stream was later used by Zinner et 
al38 following their earlier discovery39 that the human urinary stream breaks into 
drops within a few centimeters of leaving the meatus. They noted that the drops 
formed “spatial, temporal, volume, and velocity patterns” which could be 
measured by light-beam interruption methods. The data from their drop 
spectrometer were fed directly to a computer for analysis, or stored in an 
analogue or digital form on tape for further handling. An oscilloscope was used to 
provide and immediate visual readout. The velocity of each drop in the stream 
was measured by and analogue computer incorporated into the drop spectrometer 
circuitry. Once again the technique although ingenious did not provide an 
immediate permanent record, and its cost and sophistication, and the expertise 
required for interpretation of the results, rendered it unsuitable for routine clinical 
and office use. However, its potential as a urodynamic tool secured its place in 
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urologic research, and the method was later40 used to obtain the characteristic 
voiding patterns of normal and obstructed males. In this case the technique was 
extended to give an instantaneous paper tracing of  micturition by connecting the 
drop spectrometer to a PDP 11/10 computer coupled to and X-Y plotter.  
The requirement of a computer with the drop spectrometer technique was a 
presage of the future involvement of computers in urodynamic research. The 
Currently available flowmeters and their principles are illustrated below.  
 
 
 
 
 
Types of Uroflowmeters: (a) weight transducer, (b) rotating disc and (c) 
capacitance  
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Accuracy of Uroflowmeters 
 Uroflowmetry measures the flow rate of the external urinary stream as 
volume per unit time in milliliters per second, (ml/s). The ICS Technical Report41 
made technical recommendations with respect to uroflowmetry, but did not 
compare different flowmeters by specific testing. 
The desired clinical accuracy may differ from the technical accuracy of a flow 
meter. The ICS Technical report recommended the following standards: a range 
of 0–50 ml/s for Qmax, and 0–1,000 ml for voided volume, maximum time 
constant of 0.75 s; an accuracy of + 5% relative to full scale, although a calibration 
curve representing the percentage error over the entire range of measurement 
should be made available. Furthermore, as most flowmeters are mass flow meters 
(e.g., a weight transducer or rotating disk), variations in the specific gravity of the 
fluid will have a direct influence on the measured flow rate. For example, urine of 
high concentration may increase apparent flow rate by 3%. With X-ray medium, 
the flow rate may be overestimated by as much as 10%. These effects should be 
corrected by calibration software. 
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Uroflow clinic layout: The flowmeter and commode are at the foot of the 
couch with the ultrasound machine at the head of the bed. 
 
Good Urodynamic practices42  
 Adequate privacy should be provided and patients should be asked to void 
when they feel a “normal” desire to void. Patients should be asked if their voiding 
was representative of their usual voiding and their view should be documented. 
Automated data analysis must be verified by inspection of the flow curve, artifacts 
must be excluded, and verification must be documented. The results from 
uroflowmetry should be compared with the data from the patient’s own recording 
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on a frequency/volume chart. Sonographic estimation of post-void residual volume 
completes the noninvasive assessment of voiding function 
 
Normal flow 
 
Terminology relating to the description of urinary flow (International 
Continence society report, 1988) 
When considering the normality of flow rates, the patient’s age and sex and 
the voided volume should be taken into account. In addition to the numerical data 
derived from any flow trace, the shape of the trace is also important. 
In normal flow, the flow curve has a “bell” shape. Maximum flow is reached in the 
first 30% of any trace and within 5 seconds from the start of flow. The flow rate 
varies according to the volume voided 
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Maximum flow rate plotted against the volume voided for a large number of 
voids in one individual normal case. 
 
 
 
At more than 400 ml, the efficiency of the detrusor begins to decrease and Qmax 
is lower. Flow rates are highest and most predictable in the volume range 
between 200 ml and 400 ml. 
 
 
Lowest acceptable maximum urine flow rates according to age and sex for 
minimum voided volumes 
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A variety of nomograms are available and these relate maximum flow rate 
to voided volume taking sex and age into account.  
 
Siroky normogram for men under 55 years (Siroky et al. 1979)43 
 
 
Bristol normogram for men over 55 years  
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Various authorities have produced such nomograms, including Von Garrelts 
1958); Backman (1965); Gierup (1970); Siroky et al (1979); Kadow et al (1985) 
and Haylen (1990). 
 
Abnormal flow patterns 
Urine flow results from the interaction between the expressive forces (detrusor 
contraction plus any abdominal straining) and urethral resistance. Hence urine 
flow rates have limitations which must be appreciated. In free uroflowmetry, the 
shape of the flow curve may suggest specific types of abnormality, but reliable, 
specific, and detailed information about the cause for abnormal voiding cannot be 
derived from a flow curve alone. Only when uroflowmetry is combined with 
intravesical and abdominal pressure recordings does it become possible, from the 
pressure—flow relationship, to analyze separately the contributions of detrusor 
contractility and bladder outlet function to the overall voiding pattern. 
 
 
 
Detrusor overactivity 
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Bladder outlet obstruction 
 
 
 
Detrusor underactivity 
 
 
 
Straining 
 
 
 
Fluctuating detrusor contraction 
 
 22
 
Irregular trace secondary to Artefacts 
 
“Cruising” caused by a man moving his stream in relation to the central exit from 
the collecting funnel 
 
 
“Squeezing” due to patient intermittently compressing the end of his penis during 
voids 
 
Recommendations for Uroflowmetry 
In order to facilitate the recording of urine flow rate and pattern recognition of flow 
curves, it is recommended that graphical scaling should be standardized as 
follows: 
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● One millimeter should equal 1 s on the x-axis and 1 ml/s and 10 ml voided 
volume on the y-axis. 
With respect to the technical accuracy of uroflowmeters, it is meaningful for 
routine clinical measurements to read flowrate values only to the nearest full ml/s 
and volumes to the nearest 10 ml. 
In order to make electronically-read Qmax values more reliable, comparable, and 
clinically useful, we recommend internal electronic smoothing of the flow rate 
curve.  
It is recommended that: 
● A sliding average over 2 s should be used to remove positive and negative 
spike artifacts. If curves are smoothed by hand, the same concept should be 
applied. When reading Qmax graphically, the line should be smoothed by eye into 
a continuous curve so that in each period of 2 s, there are no rapid changes. Such 
a smoothed, clinically-meaningful maximum free flow Qmax will be different 
(lower) from the peak value in the flow rate recording of electronic instruments 
currently available.  
It is recommended that: 
● Only flow rate values, which have been ‘smoothed’, either electronically or 
manually, should be reported. 
If a maximum flow value is determined electronically by simple signal peak 
detection without the recommended electronic smoothing, it should be labeled 
differently, Qmax.raw. Such raw data has meaning only if a detailed specification 
of the type of flowmeter used is given. The interpretation of any dynamic variation 
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(signal patterns) in free flow will rely on personal experience, can be only 
descriptive, and in general will remain speculative. 
For the documentation of the results of uroflowmetry, the following 
recommendations are made: 
● Maximum (smoothed) urine flow rate should be rounded to the nearest whole 
number (a recording of 10.25 ml/s would be recorded as 10 ml/s); 
● Voided volume and post void residual volume should be rounded to the nearest 
10 ml (a recording of a voided volume of 342 ml would be recorded as 340 ml); 
● The maximum flow rate should always be documented together with voided 
volume and post void residual volume using a standard format: VOID: Maximum 
Flow Rate/ Volume Voided/Post Void Residual Volume. 
● If a flow/volume nomogram is used, this should be stated and referenced. 
 
Uroflowmetry in men 
Uroflow in groups of normal younger men was primarily described one to two 
decades ago44, 45, 46, 47, , 48, 49, 50, 51. From these studies on younger normal 
persons, one can deduce that Qmax declines 1 to 2 ml/s/5 years and to a 
certain degree depends on the voided volume. Some agreement exists about 
normality, because Qmax greater than 15 ml/s is considered normal, whereas 
Qmax less than 10 ml/s is considered abnormal. Gammelgaard51 described a 
decline in Qmax from 35 ml/s at the age of 14 years to 15 to 20 ml/s at the age 
of 50 years. Siroky and Krane53 found that the normal voided volume in young 
men was 250 ml +/- 100 ml. From the papers of Chancellor et al2, Cucchi54, 
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Jorgensen et al55, and Susset56 it can be concluded that acceleration in young 
men is 3.21 ml/s/s and that it, as well as other flow variables, declines as a 
person grows older. Adding acceleration to the other flow variables, however, 
does not alter the fact that it is not possible to differentiate detrusor dysfunction 
from bladder outlet obstruction on the basis of uroflowmetry. 
Studies of populations of normal men over the age of 50 years57, 58, 59, 60, 61, 62, 
63, 64, 65, 66 show that Qmax declines when compared with younger men and 
varies between 11.8 and 36 ml/s with a median value between 12.6 and 20.1 
ml/s and voided volumes of 150 to 200 ml. According to Jorgensen et al64, 65, 
median Qmax reaches 10.5 ml/s at the age of 50 years versus 5.5 ml/s at the 
age of 80 years. Furthermore only 50% voided more than 200 ml. Forty percent 
to 50% of the flow curves were normal at the age of 50 years, versus only 10% 
at the age of 80 years. 
Over the years many studies have been performed based on patients with 
different degrees of prostatism. From these investigations one can conclude 
that Qmax declines with advancing age. Residual urine increases but not as a 
direct consequence of the declining Qmax. Several nomograms of the 
Qmax/volume relation have been constructed43, 65, 67, 68 but the only true 
nomogram is a three-dimensional Qmax/volume/age nomogram. The clinical 
relevance of Qmax-nomograms is limited, however, because differentiation 
between normal and abnormal voiding in elderly men is almost impossible on 
the basis of uroflowmetry. Further, the diagnosis of infravesical obstruction per 
se does not predict risk of detrusor or renal impairment in patients suffering 
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from benign prostatic hyperplasia. Flow-curve patterns seem to have some 
prognostic value with regard to the need for surgery, but they fail to differentiate 
between the obstructed and unobstructed bladder outlet69. 
It is widely accepted that in patients with relative indications for 
prostatectomy, both symptoms and urodynamic evaluation should be 
considered. To demonstrate preoperative infravesical obstruction, one has to 
perform pressure-flow studies. From a realistic point of view, however, it 
appears justified to restrict pressure-flow studies to benign prostatic hyperplasia 
patients with Qmax over 10 ml/s. This approach would direct the need for full 
urodynamic investigation in 40% of benign prostatic hyperplasia patients with 
relative indications for treatment. Only 12% of these would require surgery for 
obstruction70. 
Uroflowmetry is an easily performed non-invasive investigation. It describes 
voiding disabilities objectively and the shape of the curve may even give some 
hints as to the cause of the disability. Two or more measurements should be 
performed and the investigation should be supplemented by adding information 
about residual urine and by keeping a voiding diary. 
Uroflowmetry in women 
Uroflowmetry in women is characterized by the shorter urethra and no 
resistance, such as that caused by the prostate gland in the male. Thus, the 
only factor influencing normal female uroflow is the voluntary part of the 
sphincteric mechanism. Normal uroflow is described only briefly in the 
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literature72, 73, 74, 75. 76. Thus, one can conclude that in the normal uroflow in 
women Qmax reaches 20 to 36 ml/s. The flow curve is bell shaped, but flowtime 
is shorter than in men. Qmax is not dependent on age.  
Pregnancy does not seem to influence uroflow, but stress incontinence does 
seem to decrease Qmax, although the shape of the curve is more 
characteristic, resembling curves from men with lower urinary tract symptoms. 
Urodynamic investigation, as a part of preoperative evaluation of women with 
incontinence, has been shown to improve cure rate77.  
In conclusion, the value of uroflowmetry in women is of some significance. 
The investigation is easy to perform and is a natural part of a urodynamic 
evaluation. If combined with a voiding diary it may give valuable hints as to 
further examinations needed to guide the most appropriate treatment. 
Uroflowmetry in children  
Urodynamics for years has had a well-established place in evaluating lower 
urinary tract dysfunction in children78. Especially uroflowmetry (Qmax) has been 
advocated in screening and posttreatment control owing to its simplicity and 
noninvasiveness. Several studies on uroflowmetry variables79, 80 have 
correlated flow variables with voiding volumes in both sexes and with age or 
body surface area. Interestingly, it was shown that in more than 90% of children 
the flow-curve patterns were identical to those of the normal adult bell-shaped 
flow curve. In the screening for functional infravesical obstruction or detrusor-
sphincter dyssynergia in neurologically normal children, uroflowmetry proved 
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inefficient as a single modality, whereas the combination of uroflowmetry with 
pressure-flow electromyogram study and residual urine measurement yielded a 
consistent diagnosis, the incidence being approximately 20%78, 80. 
Uroflowmetry as a single modality has only modest value in pediatric urology 
except in screening for occult voiding dysfunction. In a comprehensive study on 
nocturnal monosymptomatic enuresis81, it was shown that micturition disorders 
are not present in this disease entity. Similarly in children with vesicoureteral 
reflux, the cornerstone is not uroflowmetry but sophisticated overnight studies 
with monitoring of the bladder pressure82. In the evaluation of patients with 
neurogenic bladder dysfunction, cystometry and 24-hour ambulatory 
urodynamic studies are preferable with special emphasis on the bladder 
leakpoint pressure as a predictor of risk of impairment of upper urinary tract83, 84. 
 
Post void residue 
Postvoid residual (PVR) urine is the volume of fluid remaining in the 
bladder immediately after the completion of micturition. Studies indicate that PVR 
urine normally ranges from 0.09 to 2.24 ml, with the mean being 0.53 ml85. 
Seventy-eight percent of normal men have PVRs of less than 5 ml, and 100% 
have volumes of less than 12 ml86.  
PVR measurement can be performed by noninvasive (ultrasound) and by 
invasive (catheterization) methods. The most common method is by ultrasound. 
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Invasive techniques are accurate if performed correctly but carry a small risk of 
discomfort, urethral injury, UTI, and transient bacteremia (which has not been 
quantified in the literature). In addition to standard diagnostic ultrasound 
instruments for abdominal scanning, there are much smaller, portable, and less 
expensive devices to measure PVR (e.g., the BladderScan). Its reported accuracy 
is comparable with more expensive ultrasound units and catheterization. With this 
device, the mean difference between estimated PVR and “true” PVR (i.e., by 
catheterization) was 6.9 ml in 39 measurements taken in 20 children with 
neurogenic bladders88. In 164 measurements in adult patients, the correlation 
coefficient was 0.7989. 
The test-retest reliability of PVR volume is poor, regardless of the 
techniques used. Although repeated measurements may minimize the error, this 
is either costly (noninvasive techniques) or uncomfortable (invasive techniques) 
for the patient. Birch and coworkers90 reported that of 30 men with BPH, 66% had 
wide variations in PVR when three measurements were done on the same day. In 
34% of patients, there was no difference among the three measurements. In 58%, 
at least two volumes were significantly different. In 8% of patients, all three were 
different. In most patients, two measurements were statistically similar whereas 
the third one yielded quite different results. Bruskewitz and colleagues91 found 
similarly wide variations of the measured amount when they performed repetitive 
measurements of PVR (repeated two to five times) by in-and-out catheterization 
on 47 men before prostatectomy. They also found no correlation between the 
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amount of residual urine and any cystoscopic or urodynamic findings, symptoms, 
or the presence or absence of a history of UTIs. 
Most clinical studies demonstrate minimal correlation between PVR and 
baseline measurements of symptoms, flow rate, or urodynamic measures of 
obstruction. However, Neal and associates92 found a significant association in 253 
men between PVR, age, “below normal” Qmax, and high urethral resistance. Low 
voiding pressure, however, did not correlate well with PVR. The authors 
concluded that outflow obstruction is related to the development of increasing 
amounts of PVR urine. In the AUA Outcome Study, Barry and colleagues93 found 
a significant correlation between high PVR and low flow rates but no correlation 
with IPSS. 
Traditionally, urologists have assumed that increasing amounts of PVR 
denote BPH progression and are thus an “indication” for surgery. This concept 
underlies the common inclusion of PVR in each individual government's 
appropriateness criteria. Unfortunately, data are lacking to support the predictive 
value of PVR. Andersen94 studied 104 men with BPH and reported two patterns of 
BPH progression. The slow course was characterized by the development of high 
levels of PVR that resulted in decompensation of the detrusor muscle and 
eventually led to urinary retention. The fast course was associated with 
uninhibited detrusor contractions (UDCs). The amount of PVR, the presence of 
UDCs, and symptoms correlated poorly in the study. Nevertheless, Andersen 
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recommended PVR as a safety parameter when measured longitudinally 
throughout the clinical course of a patient with prostatic obstruction. 
Jensen and coworkers70 examined the prognostic value of PVR and 14 
other clinical and urodynamic variables in relation to outcome of surgery in 120 
men with clinical BPH. They found PVR the second best predictor of outcome, 
after pressure-flow studies. However, the combination of these two predictors did 
not allow the authors to correctly predict the outcome in any of 14 patients who 
failed treatment. 
Data from the Veterans Affairs (VA) Cooperative Study Group randomized 
trial comparing TURP with watchful waiting demonstrated that PVR does not 
predict the outcome of surgery, and there was little evidence to support criteria 
that require a certain amount of PVR before surgery is justified. Additionally, high 
PVR did predict a slightly higher failure rate for watchful waiting. However, the 
majority of men with large residual urine volume did not require surgery during the 
3-year duration of the trial. In summary, PVR is best viewed as a “safety 
parameter.” Men with significant PVRs should be monitored more closely if they 
elect nonsurgical therapy.  
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Aims 
The aim of this study was to compare patients’ visual assessment of 
urinary flow with uroflowmetry.  
 
Objectives 
To compare the patients’ visual assessment of urinary flow guided by the modified 
Brian Peeling diagram consisting of a multiple choice representation of various 
flow trajectories with 
~ Age 
~ Peak flow (Qmax) 
~ International Prostate Symptom Score (IPSS), and 
~ Post void residue (PVR) 
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Materials and methods 
This prospective study was conducted in the uroflow clinic of the Urology 
department. The study design and methodology was approved by the Ethics Committee 
and the Institutional Review Board. All patients were explained the nature of the study 
and an informed consent in the patient’s own language was obtained.  
Adult males, 18 years of age and older with lower urinary tract symptoms (LUTS) 
attending the uroflow clinic at the department of Urology were recruited.  Patients were 
asked to fill the IPSS questionnaire and answer a multiple choice pictorial representation 
of flow trajectory. This was done immediately before performing the uroflowmetry. 
The flow protocol was unchanged from our standard practice. Uroflowmetry was 
carried out in a lockable toilet with auto start to remove dependence on the operator. 
Patients were asked not to strain or waggle their stream. The Dantec Urodyn 1000 
rotating disk model was used after calibration. The index test was interpreted 
independently of the reference standard and without knowledge of the results. The 
uroflowmetry traces (reference standard) were assessed by an experienced observer to 
determine the ‘’true” Qmax taking into account “wag” and “straining” artefacts. Those 
unable to produce a flow volume of > 150ml were excluded. 
Immediately following the uroflowmetry, post void residue (PVR) was measured 
using transabdominal ultrasonography. 
 
 
 
 36
Statistical methods: 
 
A pilot study was conducted with 25 educated patients. The correlation between 
patients’ visual assessment of flow and the measured peak flow (Qmax) was calculated. 
The pearson’s correlation coefficient was found to be 0.81. A sample size of 60 was 
calculated for a power of 90% and an α error of 5%. A total of 100 patients were studied. 
 
Formula for calculating sample size: 
 
 
n  =          (Z1 – α/2 + Z1- β )2    
           [ ½ In (1 + r1)   -  ½ In  (1 + r0) ]2 
       (1 – r1)          (1- r0) 
 
α= significance level 
1-β= power of study 
r1= sample correlation coefficient 
r0= population correlation coefficient 
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Statistical analysis: 
 
Descriptive statistics were obtained to summarise all study variables. Relationship 
between patients’ visual assessment and uroflowmetry was obtained using spearman’s 
correlation. The presence and frequency of various lower urinary tract symptoms were 
recorded using the IPSS. The test results were compared with each of these symptoms 
to look for any correlation using spearman’s correlation. The significance of correlation 
between patients’ history and visual flow scores was determined using the Pearson chi-
square test. 
 
 
 
 
 
 
 
 
 
 
 38
 
 
 
 
RESULTS 
 39
Results 
General demographics 
 
 
 
 
 
 
 
 
 
 
A total of 100 patients were studied. The mean age of patients was 53 years. The 
median age was 56 years with a standard deviation of 13.78. Majority of the 
patients were over 50 years of age.  
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Correlation with age 
 
 
 
 
 
 
 
 
 
There was an inverse correlation between age and Peak flow (Qmax) measured 
by the uroflowmeter. This was found to be significant (p < 0.01). However, 
eventhough there was an inverse correlation between Visual flow analogues 
marked by the patients and age, it was not significant (p = 0.05). 
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Correlation with history 
 
Of the 100 patients in this study, 69 gave history of poor flow. Majority (82.5%) in 
this group marked visual flow analogues of 3 or less. 
Majority (70%) of the remaining 29 patients who did not have poor flow historically 
marked visual analogues of 4 or more. This difference was found to statistically 
significant (p < 0.01) 
 
Poor flow (n) Visual 
analogue  
%  p  
             
  YES (69)  
      
   ≤ 3  
 
82.5  
 
 
<0.001                
 NO (29) 
 
   ≥ 4  
 
70  
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Duration of symptoms 
 
 n Visual  
analogue 
% p 
Is flow 
diminished 
compared 
to 10 years 
ago 
YES (64) ≤ 3 80  
<0.001 
NO (21) ≥ 4 55 
 
Of the 100 patients studied, 64 had perceived a decrease in flow within the past 
10 years and 80% in this group marked visual analogues of 3 or less. However 
those who didn’t perceive any change in flow within the past 10 years marked 
visual analogues of 4 or more. This difference was statistically significant (p < 
0.01) 
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Correlation with peak flow 
 
 
 
 
 
Statistical analysis 
 
 
 
There was a significant correlation between between visual flow analogues and 
Qmax (p < 0.01). This correlation was found to be stronger in those who gave 
history of poor flow (p < 0.01) compared to those with a negative history (p < 
0.05).  
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Visual analogue and Qmax 
 
 
 
 
 
 
 
 
 
 
 
 
This table shows the calculated mean Qmax value representative of each visual 
flow analogue score along with their standard deviations. 
 
 
Visual 
analogue 
Mean Q max (ml/s) Standard deviation 
1 13.14 7.96 
2 13.30 6.47 
3 18.92 8.79 
4 22.83 10.06 
5 31.25 11.71 
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Visual analogue and Qmax 
 
Visual flow
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The difference between the mean Qmax values calculated for each visual 
analogue score was found to be significant (p < 0.01). However, there was 
considerable overlap between the values especially for Visual analogue scores 1 
and 2. The Pearson correlation coefficient r is 0.50. 
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Correlation with IPSS 
 
IPSS p 
Weak stream < 0.003 
Incomplete emptying < 0.001 
Total IPSS < 0.002 
QOL < 0.001 
 
Visual flow analogues had a significant inverse correlation with weak stream, 
incomplete emptying and total IPSS. Quality of life (QOL) scores also showed 
significant correlation with visual analogue scoring.  
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Correlation with PVR 
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There was an inverse relation between Visual flow analogues and PVR. However 
this correlation was weak and statistically insignificant. 
 
Visual analogue Mean PVR (ml) p 
≤ 3 50  
No significance 
≥ 4 46 
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Role of education 
 
Education p 
1-5 std No significance 
6-12 std < 0.01 
Graduate < 0.01 
 
The correlation between visual analogue scores and Qmax was significant in 
those who had received high school education or higher. 
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Discussion 
This study compares measured maximum flow rates (Qmax) with patients’ 
visual assessment of flow using a multiple choice pictorial representation of flow 
trajectory5. The Visual analogue scores marked by patients were also compared 
with their responses to 2 questions about the strength of their flow 1) do you have 
poor flow? 2) Is your flow diminished compared to 10 years ago?  
We found that there was significant correlation between history and visual 
analogue scoring. 82.5% of those who gave history of poor flow marked flow 
analogues of 3 or less and 80% of patients who noticed a decrease in flow within 
the past 10 years also marked flow analogues of 3 or less. The corresponding 
Qmax values for visual analogues 1, 2 and 3 were calculated to be 13.14, 13.30 
and 18.92 ml/s respectively. In general, patients seemed to underestimate their 
flows. 
Scott and coworkers95 and Shoukry and associates96 found that Qmax 
correlated better than symptoms with the presence or absence of obstruction as 
determined by pressure-flow studies. Abrams and associates57 studied the value 
of uroflowmetry before prostatectomy. Failure rates for surgery were found to 
decrease with the addition of flow rate measurement to symptom assessment in 
preoperative evaluation. Qmax appears to predict surgical outcome in some 
studies. In a study by Jensen et al, which included men studied with flow rates 
before and 6 months after prostatectomy97, subjective evaluation revealed an 
overall symptomatic improvement rate of 80% after surgery. The difference in 
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success rates for men falling above or below the cutoff value of Qmax = 10 mL/s 
was not significant (p = 0.2). When a Qmax cutoff of 15 mL/s was used, success 
rates for men above or below the cutoff value differed significantly. Hence, if a 
Qmax of > 15 ml/s were to represent unobstructed flow, in our study, patients who 
marked visual analogues of 1 and 2, lay below this cut off. 
This study fails to show Visual Uroflowmetry as a reliable estimator of poor 
flow when correlated with measured Qmax. The Pearson correlation coefficient r 
was 0.05. The low p value (< 0.01) represents a statistically significant difference 
in the measured mean Qmax representing each visual analogue but hides the fact 
that there is considerable overlap between values. For example, the patients who 
marked a visual analogue of 1 had a mean Qmax value of 13.14, a standard 
deviation of 7.96, and a maximum value of 26 and a minimum value of 6. The 
reasons for this wide variation in patients’ assessment may be manifold. The 
symptoms of obstruction have a slow onset and the patient’s memory of what a 
good flow is like may be blurred. Furthermore, Golomb et al98 have demonstrated 
significant circadian variations which were more marked in the group with 
symptomatic bladder outlet obstruction than in the control group, so the patient 
might not have an impression of typical flow strength. 
The severity of patients’ symptoms is still an important factor in determining 
whether to perform a prostatectomy. The International Prostate Symptom Score 
(IPSS), which is identical to the AUA Symptom Index, is recommended as the 
symptom scoring instrument to be used for the baseline assessment of symptom 
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severity in men presenting with LUTS1, 87. Diokno et al99 found little correlation 
between severity of symptoms and urodynamic finding. Anderson et al94 found 
that the only symptom that correlated with a urodynamic finding was the sense of 
incomplete emptying which correlated with residual volume. Interestingly, in our 
study, we found significant correlation between visual analogue scores and all the 
voiding symptoms represented in the IPSS including incomplete emptying. 
However, when visual analogues were compared with measured PVR, even 
though there was an inverse correlation, it was not statistically significant.  
Most clinical studies demonstrate minimal correlation between PVR and 
baseline measurements of symptoms, flow rate, or urodynamic measures of 
obstruction96. However, Neal and associates92 found a significant association in 
253 men between PVR, age, “below normal” Qmax, and high urethral resistance. 
Low voiding pressure, however, did not correlate well with PVR. The authors 
concluded that outflow obstruction is related to the development of increasing 
amounts of PVR urine. In the AUA Outcome Study, Barry and colleagues92 found 
a significant correlation between high PVR and low flow rates but no correlation 
with IPSS. 
We also studied whether the level of education of a patient had any bearing 
on the correlation between visual flow and Qmax. It was interesting to note that 
the correlation actually improved with level of education. This may reflect a higher 
degree of awareness amongst the educated, better ability to understand 
instructions and reproduce a more accurate representation of their flow. Though 
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visual uroflowmetry was developed keeping in mind a population unable to afford 
uroflowmetry, prevalence of illiteracy in our rural population is a significant 
handicap which may prevent effective utilization of this tool. 
The motivation for this study has been the knowledge that a significant 
number of prostate resections are still done without access to uroflowmetry. Lloyd 
and Kirk4 surveyed 46 respondents performing prostatectomy in Scotland of 
whom 33 were urologists and 15 were general surgeons: 36 had access to 
uroflowmetry, 13 used it with all patients, and 14 used it frequently and 9 
occasionally. 10 had no access to uroflowmetry. The situation in a developing 
country like ours may actually be much worse where the prohibitive cost of setting 
up a uroflowmetry clinic and the perceived lack of clinical utility of such an 
investigation prior to prostatectomy may contribute to the frugality of its use. 
In conclusion, our study shows that Visual Uroflowmetry had significant 
correlation with patient’s history, Qmax, voiding symptoms of the IPSS and QOL 
scores. Though it is not reliable enough to replace conventional uroflowmetry, it 
objectively quantifies a patient’s perception of his flow. It is a rapid and 
inexpensive tool which can be used to screen patients with LUTS. Further large 
scale studies are required to validate this tool and explore its use for follow up of 
patients following medical/ surgical therapy. 
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Strengths and limitations of this study 
 
This study was conducted in a preselect patient population i.e. adult males 
with LUTS attending the Uroflow clinic. Hence the results of this study cannot be 
extrapolated to the general population.  
Many Indian men squat to void. The Brian Peeling diagram5 shows various 
flow trajectories of a patient voiding in the standing position and may not have 
been relevant to many in the patient population studied. Flow trajectories have 
been depicted assuming a horizontal holding position of the penis. However, it is 
unlikely that all the patients in our study practiced a uniform holding position of the 
penis during micturition and the impact this had on assessment of flow trajectory is 
difficult to assess.  
The International Consensus Committee on BPH recommends obtaining at 
least 2 flow rate recordings each ideally with a voided volume of greater than 150 
ml to improve the validity of the test100. Our study was based on a single uroflow 
recording and may not be representative of the patient’s actual flow. We excluded 
all patients who were unable to void more than 150 ml. A number of patients who 
are not able to void a sufficient volume may have severe obstruction and are more 
likely to need quantification of symptoms prior to intervention. 
The introduction of electronically read flow variables has introduced pitfalls 
in the evaluation of uroflowmetry results. The mictiograph reads the absolute 
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maximum value uncritically, while observers evaluate the curve and neglect 
insignificant spikes or obvious artifacts. These spikes often are caused by the 
person directing the flow to different parts of the mictiograph funnel (the wag 
artifact). Urodynamically trained staff thus disagree with the electronic evaluation 
presented. The median difference in the maximum flow rate (Qmax) readings was 
shown to be 18.5% and was most pronounced in flow curves of abnormal shape 
and with low Qmax. In our study, even though all the uroflow traces were 
interpreted by a single experienced urologist, it may not have been representative 
of the patient’s actual flow. 
The sample size of this study was calculated by a pilot study of 25 educated 
patients not representative of the population of patients studied. Hence further 
studies with larger sample size need to be conducted before visual uroflowmetry 
can be validated as a screening tool. 
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CONCLUSIONS  
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Conclusions 
 
In conclusion, self assessment of urinary flow using Visual Uroflowmetry 
showed significant correlation with peak flow, total IPSS and voiding symptoms in 
the IPSS like weak stream and incomplete emptying. Significant correlation was 
also seen between patients’ assessment of flow and QOL as marked in the IPSS. 
The correlation between visual analogues and Qmax improved with level of 
education. Hence Visual uroflowmetry may be used as a rapid and inexpensive 
tool for screening patients with LUTS.  
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Informed consent document 
 
 
The department of urology at CMC, Vellore is conducting a study on uroflowmetry. 
Uroflowmetry involves the electronic recording of the urinary flow rate throughout 
the course of micturition. It is a common test used in the diagnostic evaluation of 
patients presenting with symptoms of bladder outlet obstruction. An abnormally 
low flow rate may be caused by an obstruction due to enlargement of the prostate, 
urethral stricture or due to poor function of the bladder. However, uroflowmetry is 
expensive, time consuming and may not be available everywhere. The main 
purpose of this study is to see whether a patient’s self assessment of urinary flow 
strength is comparable with uroflowmetry. 
 
If you agree to participate in this study, a doctor/ nurse will ask you to fill a 
questionnaire which will score your urinary symptoms. You will also have to 
choose a flow pattern which closely resembles your own from a multiple choice 
pictorial representation of flow trajectory. This will be followed by measurement of 
your flow rate using the uroflowmeter. 
 
Your decision not to participate in this study will not affect the care you will receive 
at the clinic in any way. Even if you do agree to become a study participant, you 
can withdraw from the study at any time (verbally) without affecting the care that 
you will receive.  The study is unlikely to expose you to any risk or cause you 
discomfort. 
 
There will be no immediate benefits from your participation in this study. If the study 
results are acceptable in terms of accuracy, it will provide a cheap and rapid method to 
screen patients with urinary symptoms coming to the clinic. There will be no monetary 
compensation for this study, but routine medical consultation and appropriate referral 
services will be available. 
 
The records concerning your participation are to be used only for the purpose of 
this research project. Any information obtained in connection with this study will be 
kept strictly confidential. Only members of the study team will have access to 
information. You can withdraw from the study at any time without affecting your 
present or future medical care at the clinic.  
 
When the researchers have analysed the data, the results and the explanation of 
its implications will be published for everyone’s information. The identity of the 
participants will not be revealed. 
 
All study related queries and problems if any should be communicated to  
Dr. NIRMAL T.J, DEPARTMENT OF UROLOGY, CMC, VELLORE. Tel: 0416-
2282111. 
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Informed consent  
 
Study Title: Comparison of patients’ assessment of urinary flow strength with 
uroflowmetry 
 
Study Number: 
Subject’s Initials: _________ Subject’s Name: ________ 
Date of Birth / Age:_______ 
Please initial box  
(Subject) 
(i) I confirm that I have read and understood the information sheet dated 
_________ for the above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected. [ ] 
(iii) I understand that the members of the research team, the Ethics Committee 
and the regulatory authorities will not need my permission to look at my health 
records both in respect of the current study and any further research that may be 
conducted in relation to it, even if I withdraw from the trial. I agree to this access. 
However, I understand that my identity will not be revealed in any information 
released to third parties or published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
 
 
 
 
 73
Questionnaire 
Name:  
Hospital no:  
Age: 
Education:  (1) 1-5 std (2) 6-12 std (3) Graduate (4) Post graduate 
Poor flow:  YES / NO 
Is the force of your flow diminished compared to 10 years ago:  YES / NO 
Post void residue:  YES / NO 
 
 
 
 
 
 
 
 
 
 
 
    2        1 
5 
 
 
4 
 
 
 
3 
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Master Data Sheet 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
 
Sno Name Hospno Age Education Flowsubj Duration PVRsubj Visflow Peakflow Meanflow Voidtime Flowtime Timepeak
1 Narayan Acharya 525637D 49 1 1 1 2 2 18 12 48 41 5
2 Maria Gregory 503336D 43 2 1 1 1 3 24 14 72 72 19
3 Radhir Prasad 525401D 56 4 1 1 3 11 6 65 65 5
4 Nirmal Das 504876D 26 2 1 1 1 2 12 8 85 49 19
5 Sheik Shamsheer 485167D 44 1 2 2 2 5 42 21 31 31 2
6 Devapalan 740169B 65 3 1 1 1 3 12 6 79 74 19
7 Rathindra Nath  525449D 58 4 1 1 1 3 23 16 29 28 13
8 Sapan Sahoo 524419D 55 2 1 1 2 2 25 14 25 25 8
9 Indranath Lahiri 490421D 39 3 2 2 1 3 50 27 72 25 2
10 Motilal 446597C 54 3 1 1 1 2 2 4 116 63 0
11 Pradip Kumar 903977C 59 3 2 2 2 5 20 13 44 43 21
12 Ranganathan 505776D 67 2 2 1 1 3 17 14 15 15 5
13 Merajuddin 520948D 44 1 5 9 3 175 166 127
14 Saran Kumar 39556D 49 1 2 1 18 9 77 32 15
15 Venkatesan 081514D 69 2 2 1 4 17 7 28 28 15
16 Renugopal 939903B 62 1 1 1 1 3 9 3 71 58 2
17 Rabindra Nath Da 523792D 69 3 2 2 2 3 5 3 81 79 7
18 Gauranga Chandr 524873D 64 2 1 1 1 1 9 4 227 130 18
19 Partha Gupta 516672D 20 2 2 2 2 4 25 15 36 36 9
20 Shib Nath 525502D 54 2 4 19 14 37 37 11
21 Shambu Nath 377766D 56 3 2 4 47 22 21 21 9
22 Murugan 515655D 43 2 1 1 1 1 12 7 87 85 26
23 Durai Pandi 515994D 28 3 1 1 1 3 13 10 59 51 3
24 Mani Mohan 917299C 61 3 1 1 2 3 3 162 85 65
25 Damodar Dholey 409139D 45 1 1 1 1 3 20 14 60 60 11
26 Suhrid Baran 523970D 57 1 1 1 4 10 5 31 29 7
27 Sourav Kumar 521667D 25 2 1 5 25 12 79 73 16
28 Anupam Acharya 521526D 28 3 2 2 1 4 30 18 59 59 16
29 Madhu Sudhan 522087D 40 2 1 1 1 2 10 5 70 70 25
30 Jose 413562B 62 3 1 1 2 4 18 9 101 78 15
31 Shamsunder 522079D 63 1 2 2 1 3 18 9 101 61 59
32 Jagadamba 522552D 61 3 1 1 1 2 20 9 50 43 20
33 Nepal Chandra 516542D 44 3 2 2 2 5 50 35 33 33 9
34 Anand 115461B 34 3 1 1 1 1 10 5 70 70 27
35 Ahmed Hussain 383962D 58 2 2 2 2 4 17 10 51 45 6
36 Dilip Kumar 520949D 66 3 1 1 2 3 10 6 31 31 6
37 Amit Banerjee 800038C 28 3 2 2 1 3 28 20 60 58 5
38 Arjun Kumar 523760D 52 3 1 1 1 2 13 7 57 55 7
39 krishna Kumar 313927C 64 3 1 1 2 3 19 10 29 29 9
Sno Name Hospno Age Education Flowsubj Duration PVRsubj Visflow Peakflow Meanflow Voidtime Flowtime Timepeak
40 Murugesan 615817C 62 1 1 1 2 2 7 3 71 60 21
41 Dhritiswar Mitra 521833D 44 3 1 1 1 3 19 11 110 83 14
42 Sanjay Kumar 707359C 40 3 1 1 2 4 20 14 68 68 6
43 Venkatesan 508706D 64 1 1 1 2 2 8 3 142 98 97
44 Ratan Chandra  430521B 71 2 1 1 2 3 15 9 25 23 5
45 Nagai Mohammad210872D 18 2 1 2 2 4 27 20 23 23 8
46 Sankari Prasad 521469D 65 3 1 1 2 3 13 5 72 57 12
47 Ramesh Prasad 710302C 51 2 1 1 1 3 8 5 91 91 24
48 Dilip Gorai 522158D 37 2 1 1 2 2 23 14 63 63 21
49 Bablu Sen 520682D 21 2 1 2 2 3 16 8 60 53 12
50 Md. Nashiruddin 515352D 48 2 1 2 1 3 20 10 65 44 5
51 Selvamoorthy 476092D 42 2 1 1 2 5 26 19 22 22 9
52 Kali Krishna 522106D 67 3 2 2 2 3 23 7 46 44 4
53 Deepak Vishwaka 476487D 38 2 1 1 1 2 14 8 62 53 8
54 Sundaram 924925O 63 4 2 2 2 2 21 9 57 54 7
55 Subramaniam 517357D 58 2 1 1 1 3 9 6 59 59 12
56 Vinayagam 447644D 42 2 1 2 2 3 29 19 39 38 8
57 Rashid 522608D 41 1 2 2 2 5 30 21 23 23 5
58 Biju C.Y 516378D 30 1 3 10 6 67 67 3
59 Ismail 492709D 56 1 1 4 6 3 67 59 11
60 Shankar 315504C 68 1 1 1 2 3 15 8 123 121 17
61 Prasun Kumar 359288D 57 1 1 1 2 19 15 20 20 8
62 Indrajit 052874C 58 3 1 1 1 3 33 20 29 29 10
63 Anup singh 552407D 67 1 1 1 3 13 6 33 32 10
64 Arun Kumar 573859D 49 1 1 1 1 8 6 66 63 10
65 John Abraham 570331D 62 2 2 2 4 40 26 21 21 7
66 Jitendra Singh 362735D 48 2 2 2 5 47 20 16 16 7
67 Paulose 548086D 45 2 2 2 4 23 10 30 30 14
68 Siya Ram Sharma 536100D 54 1 1 2 4 39 27 31 31 7
69 Vikas Mittal 479311D 29 1 1 2 3 32 32 25 25 9
70 Manas Mukherjee296874D 61 3 1 1 2 1 29 10 92 70 6
71 Kishore kumar 568207D 53 1 1 2 4 19 10 52 50 6
72 Sudhakar 576160D 67 1 1 1 1 6 5 50 33 24
73 Dwarkanath 396682A 63 3 2 2 2 4 35 19 36 34 4
74 Satyanarayana 536274D 80 1 1 2 2 12 6 56 39 8
75 Ajay Rangam 576209C 52 1 1 2 3 23 10 32 32 7
76 Shiv shakti 418405D 35 1 1 2 3 30 14 81 81 6
77 Arifulla Shah 163508D 61 1 1 2 4 16 9 96 92 22
78 Govindasamy 987004C 70 2 2 1 2 4 19 12 15 15 5
Sno Name Hospno Age Education Flowsubj Duration PVRsubj Visflow Peakflow Meanflow Voidtime Flowtime Timepeak
79 Gajapati Rao 536079D 53 2 2 2 5 28 18 13 13 4
80 Yumnam 553583C 68 1 1 2 2 9 6 37 30 25
81 Sunil 179955C 45 1 1 1 3 14 5 90 60 27
82 Purnachandra 542762D 64 1 1 2 3 15 10 56 43 7
83 Emmanuel 534230D 71 3 1 1 2 2 10 6 43 43 4
84 Swapan kumar  534969D 46 3 2 2 2 5 27 15 31 25 6
85 Chellayan 537437D 67 2 2 2 3 30 18 26 24 3
86 Rev.Thomas 537445D 80 3 1 1 2 4 25 15 30 29 8
87 Thirumalai 897010B 63 3 1 1 1 3 15 12 57 50 47
88 Srinivasan 525058D 60 3 1 1 1 4 18 8 27 20 2
89 Nikunja behari 531834D 72 3 1 1 2 2 8 4 53 35 19
90 Satyananda Mond534800D 43 1 1 1 3 25 15 37 32 4
91 Amiya Sau 531537D 71 3 1 1 2 2 13 8 26 25 6
92 Thomas 982663B 64 1 1 1 2 19 12 23 22 7
93 Md Mazmul 535643D 41 2 1 1 1 3 24 16 49 45 15
94 Sheik Mansoor 134152D 52 2 1 2 1 3 12 5 50 37 9
95 Ujjal Nair 324015D 38 2 2 1 2 5 40 19 56 49 7
96 Gurmit singh 488206D 60 2 2 1 2 4 14 8 54 53 10
97 Srinivasan 525058D 60 3 1 1 1 4 18 7 27 20 2
98 Raghunandan 532587D 62 2 2 2 3 19 10 33 29 12
99 Amal Kumar 523479D 49 2 2 2 5 31 20 34 34 13
100 Rajamani 267726D 58 2 1 1 1 3 17 7 53 47 12
Sno Voidvol Incomplete Frequency  Intermittency  Urgency weakstream Straining Nocturia QoL TotIPSS PVRobj
1 523 0 0 2 0 1 0 2 5 5 24
2 1041 0 0 0 0 5 4 2 11 62
3 409 4 5 4 5 5 5 4 6 32 45
4 409 5 5 5 4 5 0 2 26 300
5 663 0 0 0 0 0 0 0 1 63 63
6 498 0 0 2 0 0 4 2 4 8 75
7 455 1 2 0 0 1 0 0 3 4 58
8 349 0 5 0 0 2 0 2 4 9 49
9 701 0 5 1 5 0 0 2 4 13 67
10 284 4 4 2 0 3 2 3 5 18 114
11 569 0 0 0 0 0 0 1 1 1 31
12 221 0 0 0 0 0 0 3 0 3 32
13 625 0 1 0 1 0 0 3 0 5
14 291 4 0 0 0 2 0 1 7
15 208 0 1 0 4 0 0 3 2 8 94
16 191 5 4 5 3 4 3 5 6 29
17 309 0 0 1 0 0 0 3 3 4 104
18 539 3 0 4 4 4 0 3 5 18 188
19 552 1 2 3 2 3 2 2 3 14 34
20 526 0 0 5 3 5 5 3 6 21 48
21 468 0 0 1 0 0 0 0 0 1 35
22 671 14
23 515 0 2 0 1 4 3 0 5 10 15
24 265 3 4 3 4 3 0 2 3 19 42
25 842 5 2 5 4 5 4 3 1 25 59
26 171 2 1 1 2 3 1 3 5 13 123
27 896 5 3 5 4 4 5 1 27 22
28 1079 0 0 0 0 0 0 1 0 1 22
29 420 4 1 2 4 0 4 2 5 17 59
30 736 0 0 1 0 0 0 1 2 2 34
31 552 3 2 1 0 2 4 1 4 13 32
32 425 5 2 2 5 4 2 4 5 24 40
33 1169 1 0 0 0 0 0 1 0 1 18
34 414 4 2 1 1 5 5 1 5 19 0
35 487 0 1 0 0 0 0 1 2 2 52
36 187 0 0 0 0 0 0 1 1 1 10
37 1174 1 1 0 0 0 1 1 5 4 66
38 390 3 2 1 4 1 0 1 3 12 76
39 309 0 0 1 1 0 0 3 3 5 0
Sno Voidvol Incomplete Frequency  Intermittency  Urgency weakstream Straining Nocturia QoL TotIPSS PVRobj
40 228 0 2 2 2 3 1 3 3 13 0
41 985 2 1 3 0 2 1 0 2 9 21
42 960 0 1 4 0 2 1 4 2 12 0
43 374 5 2 1 0 0 3 3 5 14 0
44 219 0 0 4 3 4 0 4 3 15 33
45 469 0 1 0 2 1 2 0 0 6 0
46 333 4 1 5 0 5 5 3 6 23 48
47 484 0 0 0 1 1 2 0 1 4 15
48 938 5 4 3 5 5 0 2 6 24 0
49 455 2 1 2 0 4 2 3 6 14 0
50 474 3 4 2 0 2 0 1 4 12 49
51 409 0 0 0 1 0 0 2 0 1 75
52 344 0 1 1 5 0 0 3 4 10 7
53 444 5 1 5 5 3 0 3 5 22 59
54 500 0 0 0 0 0 0 2 0 2 28
55 357 0 1 2 2 1 0 1 1 8 49
56 744 0 1 2 0 3 3 0 5 9 37
57 484 0 5 5 0 0 0 0 3 10 35
58 419 2 5 1 5 0 0 3 6 16 15
59 217 0 5 5 5 5 0 1 5 21 286
60 966 0 1 2 0 5 5 2 3 15 59
61 297 4 3 4 5 5 0 4 4 25 67
62 588 4 4 0 4 4 2 2 5 20 10
63 186 5 5 5 1 5 0 5 6 26
64 410 4 5 5 4 5 5 3 6 31 78
65 667 0 0 0 3 3 0 3 3 9 35
66 290 0 0 0 0 0 0 1 0 1 40
67 321 0 0 0 0 0 0 2 0 2 15
68 834 0 0 0 0 0 0 1 0 1 19
69 687 1 1 0 3 2 2 5 3 14 10
70 720 1 1 0 0 0 1 4 4 3 20
71 564 0 4 0 3 0 0 1 2 8 70
72 188 4 3 3 3 4 4 3 5 24 70
73 651 2 2 4 3 3 2 2 3 18 31
74 229 0 5 0 5 0 0 5 15 36
75 357 0 2 0 5 0 0 1 2 8 51
76 1086 1 2 0 0 0 0 1 2 4 40
77 831 5 5 0 0 0 0 3 2 10 53
78 285 1 2 1 0 0 0 4 1 8 46
Sno Voidvol Incomplete Frequency  Intermittency  Urgency weakstream Straining Nocturia QoL TotIPSS PVRobj
79 245 0 0 3 5 0 0 1 1 9 23
80 196 0 1 1 0 0 0 2 2 4 46
81 316 5 4 5 0 5 5 3 5 27 56
82 434 2 2 1 0 0 0 3 5 8 66
83 270 5 3 5 3 4 0 5 3 25 21
84 393 0 0 0 0 0 0 1 1 1 24
85 429 0 5 0 4 4 5 4 5 22 17
86 454 2 1 2 2 2 3 4 3 16 20
87 663 1 1 2 0 0 0 2 4 6 31
88 155 2 1 2 5 3 2 2 5 17 8
89 157 1 1 1 1 2 1 3 3 10 21
90 475 2 1 2 0 2 0 2 3 8 34
91 224 4 0 0 5 5 3 5 2 22 91
92 277 1 1 1 2 2 1 3 3 11 23
93 745 1 1 2 4 5 2 1 6 21 16
94 209 5 4 5 5 0 0 2 6 21 21
95 985 5 3 5 4 5 0 1 6 23 140
96 457 0 1 0 0 0 0 3 3 4 19
97 155 2 1 2 5 3 2 2 5 15 8
98 295 0 1 0 0 1 0 3 4 5
99 692 2 1 2 1 2 1 3 5 12 120
100 326 5 5 5 5 3 0 5 6 27 102
